See more : Kinross Gold Corporation (K.TO) Income Statement Analysis – Financial Results
Complete financial analysis of Core One Labs Inc. (LD6.F) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Core One Labs Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- SHL Telemedicine Ltd. (0QMX.L) Income Statement Analysis – Financial Results
- LG Chem, Ltd. (051910.KS) Income Statement Analysis – Financial Results
- China Environmental Energy Investment Limited (0986.HK) Income Statement Analysis – Financial Results
- Citizens Bancorp of Virginia, Inc. (CZBT) Income Statement Analysis – Financial Results
- Kronos Strategy ETP Securities (KRON.L) Income Statement Analysis – Financial Results
Core One Labs Inc. (LD6.F)
About Core One Labs Inc.
Core One Labs Inc. operates as a biotechnology research and technology life sciences company. The company focuses on bringing psychedelic medicines to market through novel delivery systems, psychedelic assisted psychotherapy, and API grade psilocybin manufacturing. Its CannaStrips technology produces infused strips that allow for bioavailability of cannabis constituents. The company also offers consulting, financing, and micro cultivation services, as well as operates medical and wellness clinics. In addition, it provides natural health products; and news dissemination services. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 648.09K | 431.62K | 0.00 | 5.04M | 4.08M | 191.13K | 56.09K | 58.30K | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 5.71M | 5.77M | 0.00 | 0.00 | 1.60K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 648.09K | 431.62K | 0.00 | -669.57K | -1.69M | 191.13K | 56.09K | 56.70K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 100.00% | 100.00% | 0.00% | -13.28% | -41.40% | 100.00% | 100.00% | 97.26% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 70.18K | 627.29K | 97.91K | 1.12M | 1.12M | 2.71M | 65.08K | 59.06K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 8.22M | 8.36M | 5.47M | 8.13M | 7.77M | 8.67M | 1.63M | 920.79K | 304.70K | 328.25K | 459.34K | 260.27K |
| Selling & Marketing | 222.99K | 3.71M | 1.03M | 1.42M | 1.29M | 1.78M | 112.87K | 8.77K | 15.00K | 0.00 | 0.00 | 0.00 |
| SG&A | 8.45M | 12.07M | 6.50M | 9.56M | 9.06M | 10.44M | 1.74M | 929.56K | 319.70K | 328.25K | 459.34K | 260.27K |
| Other Expenses | 112.77K | 37.30K | 614.95K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 8.63M | 12.64M | 7.14M | 14.67M | 10.24M | 13.16M | 2.00M | 1.11M | 430.17K | 328.25K | 459.34K | 260.27K |
| Cost & Expenses | 8.63M | 12.64M | 7.14M | 20.38M | 16.01M | 13.16M | 2.00M | 1.11M | 430.17K | 328.25K | 459.34K | 260.27K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 4.34K | 12.65K | 0.00 | 752.00 | 2.07K | 2.57K | 109.00 | 51.00 |
| Interest Expense | 5.49K | 22.25K | 16.47K | 575.41K | 130.29K | 32.65K | 0.00 | 20.01K | 110.47K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 51.19K | 38.77K | 206.30K | 3.32M | 54.74K | 6.92K | 187.56K | 121.51K | 110.47K | 279.94K | 0.00 | 0.00 |
| EBITDA | -15.92M | -12.13M | -6.52M | -9.25M | -11.87M | -12.97M | -1.75M | -931.17K | -317.63K | -212.13K | -459.34K | -260.27K |
| EBITDA Ratio | -2,456.41% | -2,811.50% | 0.00% | -183.52% | -290.79% | -6,786.39% | -3,125.56% | -1,597.26% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -7.98M | -12.17M | -6.52M | -15.34M | -11.92M | -12.98M | -1.94M | -1.07M | -430.17K | -492.07K | -459.34K | -260.27K |
| Operating Income Ratio | -1,231.47% | -2,820.48% | 0.00% | -304.24% | -292.13% | -6,790.01% | -3,459.98% | -1,841.30% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -8.00M | -24.84M | -40.38M | 4.62M | -1.23M | -193.75K | -925.78K | -133.23K | 2.07K | 50.27K | 109.00 | 51.00 |
| Income Before Tax | -15.98M | -37.05M | -46.90M | -21.65M | -13.15M | -13.16M | -2.87M | -1.21M | -428.10K | -441.80K | -459.23K | -260.22K |
| Income Before Tax Ratio | -2,465.15% | -8,585.16% | 0.00% | -429.47% | -322.33% | -6,887.69% | -5,110.62% | -2,069.84% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 59.55K | 7.71M | 386.16K | -736.22K | -535.24K | 0.00 | 20.01K | 0.00 | -166.39K | 0.00 | 260.22K |
| Net Income | -15.98M | -37.05M | -54.62M | -21.46M | -12.29M | -12.60M | -2.87M | -1.21M | -428.10K | -441.80K | -459.23K | -260.22K |
| Net Income Ratio | -2,465.15% | -8,585.16% | 0.00% | -425.72% | -301.09% | -6,590.56% | -5,110.62% | -2,069.84% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.52 | -2.57 | -10.27 | -15.25 | -10.56 | -17.52 | -8.71 | -7.79 | -12.06 | -14.11 | -14.76 | -10.65 |
| EPS Diluted | -0.52 | -2.57 | -10.27 | -15.25 | -10.56 | -17.52 | -8.71 | -7.79 | -12.06 | -14.11 | -14.76 | -10.65 |
| Weighted Avg Shares Out | 30.75M | 14.42M | 5.32M | 1.41M | 1.16M | 718.83K | 328.95K | 154.82K | 35.50K | 31.32K | 31.11K | 24.42K |
| Weighted Avg Shares Out (Dil) | 30.75M | 14.42M | 5.32M | 1.41M | 1.16M | 718.83K | 328.95K | 154.82K | 35.50K | 31.32K | 31.11K | 24.42K |
Source: https://incomestatements.info
Category: Stock Reports